Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer Stage IV

Explore clinical trials studying Breast Cancer Stage IV. Study availability and eligibility vary by location and protocol.

37 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer Stage IV trial results

Active, Not Recruiting

Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients

NCT03870919

Conditions
Breast Cancer Stage IV, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Institut de Cancérologie de l'Ouest-Site Paul Papin Angers, France
  • Institut Sainte Catherine Avignon, France
  • Centre François Baclesse Caen, France
  • Hôpital privé sainte Marie Chalon-sur-Saône, France
View all 26 locations
View Trial Details
Active, Not Recruiting

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

NCT06234488

Conditions
Breast Adenocarcinoma, Breast Cancer, Breast Cancer Invasive, +14 more
Locations
  • University of Southern California/Los Angeles (USC/LA County) Los Angeles, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
  • University of Colorado Anschutz Medical Campus (CU Anschutz) Aurora, Colorado, United States
  • MedStar Georgetown University Hospital (MGUH) Washington D.C., District of Columbia, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer

NCT05090358

Conditions
Breast Cancer, Breast Cancer Stage IV, Breast Diseases, +6 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited protocol activity) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib

NCT05625087

Conditions
Breast Cancer Stage IV, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • CHU Amiens Picardie Amiens, France
  • Clinique de l'Europe Amiens - CTHE Amiens, France
  • Centre Hospitalier d'Auxerre Auxerre, France
  • Sainte Catherine Institut du Cancer Avignon Provence Avignon, France
View all 44 locations
View Trial Details

Related conditions